Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):507-516. doi: 10.3760/cma.j.cn112138-20211208-00869.
In recent years, no major advances have been developed in the standard treatment of primary hyperthyroidism, which mainly includes medication, radiotherapy and bilateral subtotal/total thyroidectomy. These three therapies have specific advantages and disadvantages, even traditional surgery is not appropriate for some patients due to invasive trauma, complications and neck scars. As great progresses of thermal ablation technology have been made, many domestic hospitals are carrying out this technique for hyperthyroidism. In order to improve the efficacy and safety, critical issues related to thermal ablation in patients with hyperthyroidism, including indications, contraindications, perioperative preparations, anesthesia and procedure etc, were discussed. The Chinese Medical Doctor Association, Ultrasound Intervention Professional Committee of Interventional Physician Branch of Chinese Medical Doctor Association, Professional Committee of Interventionist Branch of Chinese Medical Doctor Association, The Expert Committee of the Chinese Society of Clinical Oncology (CSCO) and the Professional Committee of the Chinese Anti-Cancer Association organized related experts and formulated this consensus based on the latest research progress.
近年来，原发性甲状腺功能亢进症的标准治疗方法没有取得重大进展，主要包括药物治疗、放射治疗和双侧次全/全甲状腺切除术。这三种疗法各有优缺点，甚至传统手术因创伤大、并发症多及颈部疤痕等问题，对一些患者并不适用。随着热消融技术的巨大进步，国内许多医院都在开展针对甲状腺功能亢进症的此项技术。为提高疗效和安全性，讨论了甲状腺功能亢进症患者热消融相关的关键问题，包括适应证、禁忌证、围手术期准备、麻醉及操作等。中国医师协会、中国医师协会介入医师分会超声介入专业委员会、中国医师协会介入医师分会专业委员会、中国临床肿瘤学会（CSCO）专家委员会及中国抗癌协会专业委员会组织相关专家，根据最新研究进展制定了本共识。
